Tamoxifen may reduce death risk in lung cancer

TREATMENT with Tamoxifen may reduce the risk of death from lung cancer in women, according to a study published in the journal Cancer.

Based on the hypothesis that blocking oestrogen could reduce the risk of death from lung cancer, researchers examined data from Switzerland’s Geneva Cancer Registry, including 6655 women diagnosed with breast cancer between 1980 and 2003.

Close to half of those women, 3066 (46%), were taking anti-oestrogen drugs.

Study lead author Dr Elisabetta Rapiti followed all those subjects until December 2007 and looked at how many developed lung cancer and how many died from the disease.

When she looked at how many women in the study were diagnosed with lung cancer, she found no significant difference between those taking anti-oestrogen therapy and those who were not. 

However, among those taking anti-oestrogen drugs, there were 87% fewer deaths from lung cancer compared with the general